Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H. T., Louthrenoo, W., Luo, S. F., . . . Morand, E. F. (2019). Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: A prospective validation study. The Lancet Rheumatology, 1(2), e95. https://doi.org/10.1016/S2665-9913(19)30037-2

Golder, Vera, et al. "Lupus Low Disease Activity State as a Treatment Endpoint for Systemic Lupus Erythematosus: A Prospective Validation Study." The Lancet Rheumatology 1, no. 2 (2019): e95. https://doi.org/10.1016/S2665-9913(19)30037-2.

Golder, Vera, et al. "Lupus Low Disease Activity State as a Treatment Endpoint for Systemic Lupus Erythematosus: A Prospective Validation Study." The Lancet Rheumatology, vol. 1, no. 2, 2019, p. e95, https://doi.org/10.1016/S2665-9913(19)30037-2.